Better ways to measure key proteins for Type 1 Diabetes
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications
This project aims to create more accurate tests for proteins and hormones in people with Type 1 Diabetes, especially children and young adults.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Pacific Northwest Laboratories NIH-funded |
| Lab location | 1 site (Richland, United States) |
| Project ID | NIH-11120936 on NIH RePORTER |
What this research studies
Type 1 diabetes often affects children and young adults, and it can be hard to track how the disease is changing or if treatments are working. Current tests for important proteins and hormones, like insulin, might not always be precise enough. This project is developing new, highly reliable tests using a method called mass spectrometry. These new tests will help doctors better understand disease progression and how well new treatments are working for patients.
Who could benefit from this research
Good fit: This research is relevant to patients, particularly children and young adults, living with or at risk for Type 1 Diabetes.
Not a fit: Patients without Type 1 Diabetes or those not interested in advanced disease monitoring methods would not directly benefit from this specific assay development.
Why it matters
Potential benefit: If successful, these new tests could provide doctors with more accurate tools to monitor Type 1 Diabetes and tailor treatments more effectively.
How similar studies have performed: While mass spectrometry is a known technique, developing highly specific, multiplexed assays for these particular Type 1 Diabetes markers using this approach is a novel and promising area.
Where this research is happening
Richland, United States
- Battelle Pacific Northwest Laboratories — Richland, United States (Active)
Researchers
- Principal investigator: Qian, Wei-Jun — Battelle Pacific Northwest Laboratories
- Study coordinator: Qian, Wei-Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.